TipRanks
Go Ultimate55% OFF

Genscript Biotech (G51) Balance Sheet

Genscript Biotech Balance Sheet

Genscript Biotech's total assets for Q2 2026 were $4.79B, a decrease of 1.36% from the previous quarter. DE:G51 total liabilities were $881.62M for the fiscal quarter, a 0.61% an increase from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Dec 22Dec 21
$ 4.85B$ 5.28B$ 3.39B$ 2.55B$ 2.23B
$ 876.30M$ 954.91M$ 1.34B$ 1.18B$ 846.17M
$ 3.96B$ 4.32B$ 2.04B$ 1.36B$ 1.39B

Currency in USD

Genscript Biotech Debt to Assets

02B4B6B0 %25 %50 %75 %LiabilitiesDebt to Assets201720182019202020212022202320242025AssetsLiabilitiesDebt to Assets